MedPlast invests in high-end niche

By Roger Renstrom
Correspondent

Published: March 26, 2013 2:29 pm ET
Updated: March 26, 2013 2:33 pm ET

Image By: Roger Renstrom From left, MedPlast's Matthew Langdon, Harold Faig and Barbara Glenn

Related to this story

Topics Medical, Injection Molding

ANAHEIM, CALIF. — MedPlast Inc. continues to evolve as a diverse, vertically integrated, custom plastics processor for health-care and commercial markets.

The Tempe, Ariz.-based firm — which operates 14 facilities in the U.S., China and Mexico — invests about $5 million a year in plants and equipment, according to CEO Harold Faig.

In March, MedPlast fired up two new Aoki four-cavity injection stretch blow molding machines at its medical-certified site in Tijuana, Mexico — an equipment investment of more than $1 million.

Faig said the company must address changes in the demand for high regulatory compliance while creating value-added products.

"We are building our requirements around capabilities to manufacture things no one else wants to do," he said. MedPlast encourages customers to "give us your difficult products," Faig said in a Feb. 13 interview at the Medical Design & Manufacturing West trade show in Anaheim.

The company projects 2013 sales "north of $250 million," after recording $222 million last year, Faig said. That sales growth will come from existing business as well as new opportunities, according to Matthew Langdon, executive vice president of sales and marketing.

In various locations, MedPlast has thermoplastic, silicone and rubber molding capabilities, and the firm can package, sterilize and ship to destination, Faig said.

In all, MedPlast operates more than 400 presses for injection molding and blow molding. In the U.S., Faig claims that no other firm offers extrusion blow molding, injection blow molding and injection stretch blow molding. "Med­- Plast has more two-shot capability than anyone else [in the U.S.] and more kinds of two-shot capability than anyone else," Faig said. Most of that capability is for health-care work, he added.

For injection molding, MedPlast presses have clamping forces of 3-1,000 tons, though most are in the 50- to 400-ton range, Faig said.

"As we added plants, we needed to be an extension of our customers' manufacturing processes," Faig said.

"Customers want integrated capabilities," Langdon said.

A customer project that has been two years in development at MedPlast's West Berlin, N.J., facility is currently undergoing clinical reviews. MedPlast performed finite analysis, did design-for-manufacturability work, created the tool and molded the top piece of a knee replacement using medical-grade polyetheretherketone.

"They wanted a net shape on the finished part," Faig said. The knee-replacement part bolts to a titanium plate and rod.

Later this year MedPlast expects to receive permission from China's State Food and Drug Administration for a bioburden testing laboratory there. The firm first applied for authorization in 2011.

Also during 2013, MedPlast is transferring some of its technological capabilities to Suzhou, China, to complement production at its elastomer-focused plant in Elkhorn, Wis. The firm moved two injection blow molding machines in the first quarter, and plans to transfer Elkhorn capabilities for two-shot molding and silicone molding during the third quarter. While sharing knowledge, the Elkhorn plant remains busy with significant production volumes, according to Faig.

Baird Capital Partners of Chicago owns the majority share of MedPlast; management owns about 20 percent.

Private equity investors include River Cities Capital Funds of Cincinnati and the Chicago office of Jordan Co. LP.

Last year MedPlast and its investors acquired fellow contract manufacturer United Plastics Group Inc. of Oak Brook, Ill., adding significant reach and production capacity in China — as well as Langdon, who was with UPG for 10 years.

MedPlast completed a restructuring of the UPG operations in November, with the MedPlast brand concentrating on the medical business in nine plants and the UPG brand on specialty industrial markets in five plants.

MedPlast was formed in 2008 from a combination of two Baird acquisitions: Wayne, Pa.-based Applied Tech Products Corp.'s engineered rubber and plastics group and K&W Medical Specialties of Westfield, Pa. Baird is the U.S.-based buyout fund of Baird Private Equity, an affiliate of Robert W. Baird & Co.

Faig, a longtime member of Baird's advisory board, joined MedPlast as CEO. Previously, he was president and CEO of injection molder Tech Group Inc. of Scottsdale, Ariz. He was instrumental in selling Tech Group to West Pharmaceutical Services Inc. in May 2005. Faig had been on Tech's board of directors since 1991.

Faig retired from Milacron Inc. in August 2003 after a long career with the Cincinnati-based plastics equipment maker. He was Milacron's president and chief operating officer.

Faig said that in assembling MedPlast operations, he pursued a strategy of grouping the plants in North America. "We wanted to serve the geographic concentrations for health care," he said.

MedPlast's Northeast facilities are in West Berlin; Westfield; and Chicopee, Mass. Central sites are Elkhorn; Monticello, Iowa; Minneapolis; and Houston. Western sites are Tempe; Tijuana; and Fremont, Calif. Four plants are in China.

Among the acquired UPG assets is mold-making capability in Suzhou. "We moved the UPG mold-making shop to another Suzhou building to consolidate mold making with medical molding," Faig said. MedPlast makes molds only for medical products and only for internal use, he said.

MedPlast produces high-end, implantable components using exotic biocompatible materials like titanium, cobalt chromium and tantalum in screws, bolts and anchors, and using polymers in pessary and orthopedic devices, ocular plugs and hydrocephalus shunts.

MedPlast employs about 1,700, and in the past year has added more sales support, Faig said.


Comments

MedPlast invests in high-end niche

By Roger Renstrom
Correspondent

Published: March 26, 2013 2:29 pm ET
Updated: March 26, 2013 2:33 pm ET

Post Your Comments


Back to story


More stories

Image

Somple named president of Mack Molding

September 2, 2014 4:30 pm ET

Jeff Somple, president of Mack Molding Inc.'s Northern division, has been promoted to president of all of Mack Molding Inc.    More

Image

GI Plastek to open expanded N.H. plant

September 2, 2014 3:02 pm ET

GI Plastek Wolfeboro LLC, a custom structural foam and injection molder of medium and large parts, is unveiling a 35,000-square-foot expansion this...    More

Image

Material Insights: Nova Chemicals breaks ground for PE research

September 2, 2014 1:06 pm ET

Polypropylene prices climb 5 cents, Nova Chemicals expanding research center and Sinopec licenses technology to a U.S. plant.    More

Image

Minnesota Rubber & Plastics has new leader, new focus

September 2, 2014 12:18 pm ET

With new leadership, Minnesota Rubber & Plastics is setting the foundation for long-term success.    More

Image

Baxter investing $300 million to expand dialyzers production in Alabama

August 29, 2014 12:53 pm ET

Baxter International, Inc. is expanding its Opelika, Ala. manufacturing location to boost production of dialyzers, a key component of hemodialysis the...    More

Market Reports

Thermoformed Packaging 2014 Market Review & Outlook North America

This in-depth report analyzes economic and market trends, legislative/regulatory activity impacting supply and demand, business opportunities and threats, materials pricing, manufacturing technology, as well as growth strategies being implemented by thermoformed packaging companies.

Learn more

Pipe, Profile & Tubing Extrusion in North America 2014

U.S. demand for extruded plastics is expected to grow by 3 percent in 2014, with PVC remaining the largest segment.

Plastic pipe will post the strongest gains through 2018, continuing to take market share from competing materials in a range of markets.

Our latest market report provides in-depth analysis of current trends and their financial impact on the pipe, profile and tubing extrusion industry in North America.

Learn more

2014 Injection Molding Industry Report

GROWTH, OPPORTUNITY IN SIGHT FOR INJECTION MOLDERS IN 2014

In the wake of the economic turbulence earlier in this decade, molders today find themselves in much better shape. Molders are gaining a competitive advantage by investing in people, equipment and seeking inroads into new markets on a global scale.

Growth in the injection molding industry is going to be driven by low financing costs and a continued move to reshore some business.

Learn more

Upcoming Plastics News Events

September 10, 2014 - September 12, 2014Plastics Caps & Closures 2014

January 14, 2015 - January 14, 2015Plastics in Automotive

February 4, 2015 - February 6, 2015Plastics News Executive Forum 2015

More Events